We're building the future of AI and biology together.
SynBioBeta 2027, May 3-6, San Jose.
Reagan
Jarvis
Anocca AB
CEO, Co-founder
Alex
Rives
CZI Biohub
Head of Science
Karen
Akinsanya
Schrodinger
President, R&D – Therapeutics
Christopher
Arendt
Takeda
CSO, Head of Research
Stef
van Grieken
Cradle
CEO
Michael
Koeris
DARPA
Director, BTO
Jennifer
Dionne
Pumpkinseed
CEO
Daniyal
Hussain
GSK
Exec. Dir., Tech BD
Cynthia
Hong
Novartis
Dir., Search & Evaluation
Sarah Lynn
Tao
CSL Behring
Sr. Dir., S&E; Ig TA & Tech Lead
Ziwei
Liang
Pfizer
Innovation Fellow & Director
Jose Carlos Garcia-Garcia
Procter & Gamble
Sr. Dir., Research Fellow
Joe
Hedley
NunaBio
CEO
Meet the Sponsors & Exhibitors
3dr
Acrisure
Agentic Bio
Aminoverse
Andgel Industrial (Shanghai) Co., Ltd.
Anocca AB
Ansa Biotechnologies
Bay Area Cancer Connections
Bio Base Europe Pilot Plant
Bold View Capital
Centivax
Cradle
Dyno Therapeutics
EverGlade Consulting
Evonik
Federov
Flock Bio
Frontiers
Gator Bio
Genoa Ventures
Genomic Intelligence
Genyro
GRIDX
Hamilton Company
IKA Works
Ingenza
Joint BioEnergy Institute (JBEI)
Korea Institute Of Science And Technology
Lab Thread
Matterworks
Miibio
New England Biolabs
NunaBio
Omega Bio-Tek
Origenity
Procter & Gamble
Pumpkinseed
Solaris Biotech by Donaldson
Substrate Bio
Sunthetics AI
Talaria Biosciences
The Bioforge
Twig
Twist Bioscience
Xellsion.AI
Bunker Bio
Chromatin Bioscience
DoriNano Inc
Why People Keep Coming Back
”
SynBioBeta is a who’s who of AI and biology. This is where the future is being built, so don't miss it.
Eric Schmidt
Former CEO
”
Nabla was accelerated into existence because of SynBioBeta. I met Seth Bannon from 50 Years, Cee Cee Schnugg from Boom Capital, and others from Y Combinator there, and those same people seeded Nabla. The vibe, leverage, and energy at SynBioBeta are unreal.
Surge Biswas
Founder
”
I met Algen at SynBioBeta and later invested in the company. It's exactly the kind of connection that makes the community so valuable.
Bill Tai
Co-founder
”
For every single fund at Boom Capital, one of our best companies has come directly from SynBioBeta. I met Mammoth Bio at SynBioBeta, and I met Nabla Bio at SynBioBeta.
Celestine Schnugg
Founder
AI-powered therapeutics, precision medicine, and longevity. The founders, the pharma leaders, and the investors.
View Theme
Synthesis, editing, multi-omics, and automation — the stack from base pair to bioreactor. The toolmakers, the platform builders, and the labs that run on them.
View Theme
Foods, materials, chemicals, and ingredients made by biology — and priced to win. The founders, the manufacturers, and the buyers scaling them.
View Theme
Where bio capital actually moves — deals, valuations, and non-dilutive funding. The VCs, the philanthropists, and the founders raising.
View Theme
Foundation models, virtual cells, AI-designed molecules, and the companies putting them to work.
View Theme
Synthesis screening, countermeasure capacity, and governance racing the tools. The scientists, the agencies, and the policymakers holding the line.
View Theme
Advance Discount Ends Midnight Monday, November 30. Lock In Your Rate Now.
All passes are fully refundable.
Students: Join our Next-Generation Leaders Program
Secure Your Spot in the Exhibit Hall
